 | Pfizer And Lilly Announce Positive Results From Phase 3 Trial Of Tanezumab
www.nasdaq.com - July 18 at 8:23 AM |
 | Pfizer and Lilly's tanezumab successful in late-stage osteoarthritis pain study
seekingalpha.com - July 18 at 8:23 AM |
 | Pfizer And Lilly Announce Positive Top-Line Results From Phase 3 Trial Of Tanezumab For The Treatment Of Osteoarthritis (OA) Pain
finance.yahoo.com - July 18 at 8:23 AM |
| Pfizer-Lilly pain drug found effective in late-stage study
finance.yahoo.com - July 18 at 8:23 AM |
 | Eli Lilly And Co (LLY) Given "Buy" Rating at Cantor Fitzgerald
www.americanbankingnews.com - July 17 at 6:46 PM |
| Eli Lilly And Co (LLY) Price Target Raised to $90.00 at Bank of America
www.americanbankingnews.com - July 17 at 2:38 PM |
| Eli Lilly And Co (LLY) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - July 17 at 1:56 AM |
| Analyst Recommendations for Valeant Pharmaceuticals in July
finance.yahoo.com - July 16 at 4:40 PM |
| Jefferies Financial Group Analysts Give Eli Lilly And Co (LLY) a $100.00 Price Target
www.americanbankingnews.com - July 16 at 9:52 AM |
| Credit Suisse Group Analysts Give Eli Lilly And Co (LLY) a $84.00 Price Target
www.americanbankingnews.com - July 15 at 4:34 AM |
| New Lilly Diabetes helpline to Assist People Seeking Solutions to Insulin Affordability
finance.yahoo.com - July 12 at 8:30 AM |
 | Rimidi Closes $6.575 Million Series A with Strategic Investment from Eli Lilly
www.bizjournals.com - July 11 at 8:25 AM |
| Zacks: Brokerages Expect Eli Lilly And Co (LLY) Will Announce Quarterly Sales of $6.10 Billion
www.americanbankingnews.com - July 11 at 1:48 AM |
| Highmark, pharmaceutical company reach deal on diabetes drug
www.bizjournals.com - July 10 at 4:50 PM |
| Eli Lilly And Co (LLY) Given a $100.00 Price Target at Cantor Fitzgerald
www.americanbankingnews.com - July 10 at 10:28 AM |
| Brokerages Anticipate Eli Lilly And Co (LLY) Will Post Earnings of $1.34 Per Share
www.americanbankingnews.com - July 9 at 4:14 PM |
 | Biogen Shares Soar on Positive Alzheimer's Drug Results
www.thestreet.com - July 7 at 4:36 PM |
| Eli Lilly And Co (LLY) Major Shareholder Sells $14,725,400.00 in Stock
www.americanbankingnews.com - July 6 at 12:12 PM |
| Developments for Eli Lilly in June Include EASE Phase 3 Data
finance.yahoo.com - July 3 at 9:06 AM |
| Eli Lilly And Co (LLY) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - July 2 at 7:08 PM |
| Eli Lilly’s Animal Health Business
finance.yahoo.com - July 2 at 4:36 PM |
| Analysts’ Estimates and Recommendations for Eli Lilly in June
finance.yahoo.com - July 2 at 4:36 PM |
| Eli Lilly’s Cardiovascular Product Portfolio
finance.yahoo.com - July 2 at 8:41 AM |
| Blog Exposure - Eli Lilly's Taltz(R) Meets Primary Endpoint in Phase-3 Study for Treatment of Ankylosing Spondylitis
finance.yahoo.com - July 2 at 8:41 AM |
| Eli Lilly’s Oncology Product Portfolio
finance.yahoo.com - June 30 at 8:28 AM |
| Lilly's (LLY) Taltz Positive in Ankylosing Spondylitis Study
finance.yahoo.com - June 30 at 8:28 AM |
 | Lilly (LLY) Initiates Observational Survey of Epidemiology, Treatment and Care of Migraine
www.streetinsider.com - June 29 at 9:28 AM |
| Lilly Confirms Date and Conference Call for Second-Quarter 2018 Financial Results Announcement
finance.yahoo.com - June 29 at 9:28 AM |
| Eli Lilly’s Human Pharmaceuticals Business
finance.yahoo.com - June 29 at 9:28 AM |
| LLY Announces Results for Emgality in Episodic Cluster Headaches
finance.yahoo.com - June 29 at 9:28 AM |
| Lilly Announces Initiation of the Observational Survey of the Epidemiology, Treatment and Care of Migraine (OVERCOME) to Advance Understanding of Burden, Impact and Epidemiology of Migraine
finance.yahoo.com - June 29 at 9:28 AM |
| Eli Lilly’s Neuroscience Product Portfolio
finance.yahoo.com - June 29 at 9:28 AM |
| Eli Lily Highlights Study Results of Emgality for Migraines
finance.yahoo.com - June 29 at 9:28 AM |
 | Eli Lilly reports positive results in trial of treatment for Ankylosing Spondylitis
www.marketwatch.com - June 28 at 9:31 AM |
| Eli Lilly’s Q1 2018 Top Line Rose 9% to $5.7 Billion
finance.yahoo.com - June 28 at 9:31 AM |
| The Zacks Analyst Blog Highlights: Amazon, Intel, Eli Lilly, Illinois Tool Works and Southern
finance.yahoo.com - June 28 at 9:31 AM |
| Eli Lilly’s Business Segments: Growth and Trends
finance.yahoo.com - June 28 at 9:31 AM |
| AHS 2018: Lilly Highlights Positive Phase 3 Results from the Largest Controlled Preventive Trial in Episodic Cluster Headache
finance.yahoo.com - June 27 at 5:41 PM |
| Top Research Reports for Amazon, Intel & Eli Lilly
finance.yahoo.com - June 27 at 5:41 PM |
| A Look at Eli Lilly’s Valuations on June 25
finance.yahoo.com - June 27 at 5:41 PM |
| AHS 2018: Lilly's Emgality™ (galcanezumab-gnlm) Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed BOTOX®* (onabotulinumtoxinA)
finance.yahoo.com - June 27 at 5:41 PM |
| Eli Lilly & Co. (LLY) and Boehringer Ingelheim Announce Update from Two New Analyses from EMPA-REG OUTCOME Trial,
www.streetinsider.com - June 26 at 9:27 AM |
| Eli Lilly To Present Phase 3 Data For Galcanezumab, Lasmiditan - Quick Facts
www.nasdaq.com - June 25 at 9:18 AM |
| Boehringer Ingelheim & Eli Lilly: Empagliflozin Trials Meet Primary Endpoint
www.nasdaq.com - June 25 at 9:18 AM |
| Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes
finance.yahoo.com - June 25 at 9:18 AM |
| Lilly to Present Phase 3 Data at AHS 2018 Highlighting Innovative Potential Treatments for Migraine and Cluster Headache
finance.yahoo.com - June 25 at 9:18 AM |
| First-ever Study of Lilly's Humulin® R U-500 Administered in an Insulin Pump Shows Improved A1C in People with Type 2 Diabetes
finance.yahoo.com - June 25 at 9:18 AM |
| Lilly's Jardiance meets main goal of two diabetes trials
finance.yahoo.com - June 25 at 9:18 AM |
| Eli Lilly and Company (NYSE:LLY) Is Trading At A 23.26% Discount
finance.yahoo.com - June 24 at 6:29 PM |
| 5 Biggest Blockbuster Diabetes Drugs of the Future
finance.yahoo.com - June 24 at 9:06 AM |
